Acrivon Competitors and Similar CompaniesClear all

Acrivon's competitors and similar companies include Iksuda Therapeutics and OncoTherapy Science.

	Acrivon Acrivon (also known as Acrivon Therapeutics) is a clinical-stage oncology company that leverages a precision medicine platform called Acrivon Predictive Precision Proteomics (AP3) for the development of a drug pipeline.	Iksuda Therapeutics Iksuda is a biotechnology company that focuses on developing antibody-based therapies for the treatment of cancer.	OncoTherapy Science OncoTherapy Science is a company engaged in research and development of cancer therapeutics.
Founding Date	Founding Date 2018	Founding Date 2007	Founding Date 2001
Type	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy
Locations	Locations Watertown, US HQ Lund, SE	Locations Newcastle upon Tyne, GB HQ Newton, US	Locations Kawasaki, JP HQ
Employees	Employees 415% increase	Employees 43	Employees 54
Valuation ($)	Valuation ($) 256.1 m	Valuation ($) N/A	Valuation ($) 56.9 m
Financial
Net income	Net income ($77.9m) (FY, 2025)	Net income N/A	Net income (¥910.6m) (FY, 2026)

For sources of this data, please see the company profile

Newcastle upon Tyne, GB

Employees

Iksuda is a biotechnology company that focuses on developing antibody-based therapies for the treatment of cancer.

Kawasaki, JP

Employees

OncoTherapy Science is a company engaged in research and development of cancer therapeutics.

Financial